Voc Diagnostics

AOA Diagnostics

This biotech company develops AI-enabled liquid biopsy blood tests to detect early-stage ovarian cancer in symptomatic women.

OXCan

This company develops blood tests using proteomics and machine learning to enable early cancer detection for healthcare providers and patients.

CanSense

This company develops blood-based diagnostic tests using laser spectroscopy and artificial intelligence for early-stage bowel cancer detection for healthcare providers and laboratories.

Pictura Bio

This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.

AOA

This company develops non-invasive liquid biopsy blood tests for the early detection of ovarian cancer for healthcare providers and patients.

Digistain

This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.

Epiliquid

This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.

Oxford Cancer Analytics

The company develops liquid biopsy blood tests using proteomics and machine learning for early lung cancer detection for healthcare providers and screening programmes.